Agentes hipolipidémicos: ¿Para qué son buenos?

Interaction between nonsteroidal anti-inflammatory drug intake and calcium-channel blocker-based antihypertensive treatment in the Syst-Eur trial.

Journal of human hypertension·2001

Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the Seven Countries Study.

Thorax·2001

Mealtime glucose regulation in type 2 diabetes.

International journal of clinical practice·2001

Socioeconomic status and ischemic stroke: The FINMONICA Stroke Register.

Stroke·2001

Linkage disequilibrium between microsatellite markers extends beyond 1 cM on chromosome 20 in Finns.

Genome research·2001

Socioeconomic inequalities in the incidence, mortality and prognosis of subarachnoid hemorrhage: the FINMONICA Stroke Register.

Cerebrovascular diseases (Basel, Switzerland)·2001

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Two undescribed bisabolane-type sesquiterpenoids from the endophytic fungus Penicillium herquei.

Journal of Asian natural products research·2026

In Vitro Effects of Centaurea ovina (Roudbari Cornflower) Aqueous and Ethanolic Extracts on Staphylococcus saprophyticus: Growth Inhibition, Antibiofilm Activity, and Reduced ureC/uafA Transcripts.

International journal of microbiology·2026

Sperm-disrupting activity of a root bark fraction of Flueggea virosa (Roxb. ex willd.) royle uncovered using LC-MS/MS profiling and functional evaluation.

Frontiers in pharmacology·2026

The relevance of cannabinoid receptor 2 in the central nervous system: an update over the last 3 years.

Frontiers in behavioral neuroscience·2026

Do sigma-1 receptor agonists offer therapeutic promise for Alzheimer's disease?

Expert opinion on pharmacotherapy·2026

Protective Effects of Geraniol in Rheumatoid Arthritis Through Attenuation of Inflammation and Oxidative Stress.

Endocrine, metabolic & immune disorders drug targets·2026

Videos de Experimentos Relacionados

Agentes hipolipidémicos: ¿Para qué son buenos?

Videos de Conceptos Relacionados

Interaction between nonsteroidal anti-inflammatory drug intake and calcium-channel blocker-based antihypertensive treatment in the Syst-Eur trial.

Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the Seven Countries Study.

Mealtime glucose regulation in type 2 diabetes.

Socioeconomic status and ischemic stroke: The FINMONICA Stroke Register.

Linkage disequilibrium between microsatellite markers extends beyond 1 cM on chromosome 20 in Finns.

Socioeconomic inequalities in the incidence, mortality and prognosis of subarachnoid hemorrhage: the FINMONICA Stroke Register.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Two undescribed bisabolane-type sesquiterpenoids from the endophytic fungus <i>Penicillium herquei</i>.

In Vitro Effects of <i>Centaurea ovina</i> (Roudbari Cornflower) Aqueous and Ethanolic Extracts on <i>Staphylococcus saprophyticus</i>: Growth Inhibition, Antibiofilm Activity, and Reduced <i>ureC</i>/<i>uafA</i> Transcripts.

Sperm-disrupting activity of a root bark fraction of <i>Flueggea virosa</i> (Roxb. ex willd.) royle uncovered using LC-MS/MS profiling and functional evaluation.

The relevance of cannabinoid receptor 2 in the central nervous system: an update over the last 3 years.

Do sigma-1 receptor agonists offer therapeutic promise for Alzheimer's disease?

Protective Effects of Geraniol in Rheumatoid Arthritis Through Attenuation of Inflammation and Oxidative Stress.

Videos de Experimentos Relacionados

Agentes hipolipidémicos: ¿Para qué son buenos?

Videos de Conceptos Relacionados

Artículos Relacionados